ACIU
Price
$2.10
Change
+$0.06 (+2.94%)
Updated
Jun 9, 04:59 PM (EDT)
Capitalization
204.84M
58 days until earnings call
ARCT
Price
$12.52
Change
-$0.27 (-2.11%)
Updated
Jun 9, 04:59 PM (EDT)
Capitalization
346.87M
63 days until earnings call
Interact to see
Advertisement

ACIU vs ARCT

Header iconACIU vs ARCT Comparison
Open Charts ACIU vs ARCTBanner chart's image
AC Immune SA
Price$2.10
Change+$0.06 (+2.94%)
Volume$951
Capitalization204.84M
Arcturus Therapeutics Holdings
Price$12.52
Change-$0.27 (-2.11%)
Volume$8.91K
Capitalization346.87M
ACIU vs ARCT Comparison Chart
Loading...
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACIU vs. ARCT commentary
Jun 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACIU is a StrongBuy and ARCT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 10, 2025
Stock price -- (ACIU: $1.68 vs. ARCT: $11.82)
Brand notoriety: ACIU and ARCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACIU: 27% vs. ARCT: 77%
Market capitalization -- ACIU: $204.84M vs. ARCT: $346.87M
ACIU [@Biotechnology] is valued at $204.84M. ARCT’s [@Biotechnology] market capitalization is $346.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACIU’s FA Score shows that 0 FA rating(s) are green whileARCT’s FA Score has 0 green FA rating(s).

  • ACIU’s FA Score: 0 green, 5 red.
  • ARCT’s FA Score: 0 green, 5 red.
According to our system of comparison, ACIU is a better buy in the long-term than ARCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACIU’s TA Score shows that 4 TA indicator(s) are bullish while ARCT’s TA Score has 6 bullish TA indicator(s).

  • ACIU’s TA Score: 4 bullish, 2 bearish.
  • ARCT’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, ARCT is a better buy in the short-term than ACIU.

Price Growth

ACIU (@Biotechnology) experienced а +1.82% price change this week, while ARCT (@Biotechnology) price change was -2.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.00%. For the same industry, the average monthly price growth was +19.89%, and the average quarterly price growth was +5.86%.

Reported Earning Dates

ACIU is expected to report earnings on Aug 06, 2025.

ARCT is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+11.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARCT($347M) has a higher market cap than ACIU($205M). ARCT YTD gains are higher at: -30.348 vs. ACIU (-37.778). ACIU has higher annual earnings (EBITDA): -48.62M vs. ARCT (-77.4M). ARCT has more cash in the bank: 237M vs. ACIU (165M). ACIU has less debt than ARCT: ACIU (5.43M) vs ARCT (28.6M). ARCT has higher revenues than ACIU: ARCT (138M) vs ACIU (27.3M).
ACIUARCTACIU / ARCT
Capitalization205M347M59%
EBITDA-48.62M-77.4M63%
Gain YTD-37.778-30.348124%
P/E RatioN/AN/A-
Revenue27.3M138M20%
Total Cash165M237M70%
Total Debt5.43M28.6M19%
FUNDAMENTALS RATINGS
ACIU vs ARCT: Fundamental Ratings
ACIU
ARCT
OUTLOOK RATING
1..100
1610
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9796
PRICE GROWTH RATING
1..100
6588
P/E GROWTH RATING
1..100
84100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARCT's Valuation (47) in the Pharmaceuticals Major industry is in the same range as ACIU (50). This means that ARCT’s stock grew similarly to ACIU’s over the last 12 months.

ARCT's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as ACIU (100). This means that ARCT’s stock grew similarly to ACIU’s over the last 12 months.

ARCT's SMR Rating (96) in the Pharmaceuticals Major industry is in the same range as ACIU (97). This means that ARCT’s stock grew similarly to ACIU’s over the last 12 months.

ACIU's Price Growth Rating (65) in the Pharmaceuticals Major industry is in the same range as ARCT (88). This means that ACIU’s stock grew similarly to ARCT’s over the last 12 months.

ACIU's P/E Growth Rating (84) in the Pharmaceuticals Major industry is in the same range as ARCT (100). This means that ACIU’s stock grew similarly to ARCT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACIUARCT
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 13 days ago
88%
Bullish Trend 13 days ago
79%
Momentum
ODDS (%)
Bullish Trend 13 days ago
80%
Bearish Trend 13 days ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 13 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 13 days ago
86%
Bearish Trend 13 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 13 days ago
71%
Bearish Trend 13 days ago
87%
Advances
ODDS (%)
Bullish Trend 21 days ago
73%
Bullish Trend 21 days ago
80%
Declines
ODDS (%)
Bearish Trend 27 days ago
87%
Bearish Trend 13 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 13 days ago
71%
N/A
Aroon
ODDS (%)
Bullish Trend 13 days ago
76%
Bullish Trend 13 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ACIU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACIU has been loosely correlated with RGNX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACIU jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACIU
1D Price
Change %
ACIU100%
-0.59%
RGNX - ACIU
41%
Loosely correlated
-5.84%
ARCT - ACIU
38%
Loosely correlated
-1.75%
RCKT - ACIU
38%
Loosely correlated
+6.44%
TECH - ACIU
36%
Loosely correlated
-1.56%
STOK - ACIU
35%
Loosely correlated
+2.72%
More

ARCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARCT has been loosely correlated with BMEA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ARCT jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARCT
1D Price
Change %
ARCT100%
-1.75%
BMEA - ARCT
51%
Loosely correlated
-2.11%
TRDA - ARCT
50%
Loosely correlated
+0.91%
ABCL - ARCT
50%
Loosely correlated
+3.03%
BNTX - ARCT
46%
Loosely correlated
-1.04%
RCKT - ARCT
46%
Loosely correlated
+6.44%
More